Advanced BioMedical Technologies, Inc. (ABMT)
OTCMKTS · Delayed Price · Currency is USD
0.0002
-0.0002 (-50.00%)
At close: Jan 8, 2026

ABMT Ratios and Metrics

Millions USD. Fiscal year is Nov - Oct.
Fiscal Year
CurrentFY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Jan '26 Oct '20 Oct '19 Oct '18 Oct '17 Oct '16
011415813
Market Cap Growth
-99.88%152.08%-70.99%75.83%-37.99%68.60%
Enterprise Value
-1710201217
Last Close Price
0.000.150.060.210.120.20
PS Ratio
0.1386.63364.34---
PB Ratio
0.00-1.45-0.66-2.60-1.67-3.08
P/FCF Ratio
-17.38----
P/OCF Ratio
1.5516.56----
EV/Sales Ratio
-135.03850.81---
EV/FCF Ratio
-27.09----
Debt / Equity Ratio
-0.78-0.76-0.89-0.90-0.87-0.86
Debt / FCF Ratio
-9.13----
Net Debt / Equity Ratio
-0.78-0.73-0.88-0.90-0.87-0.86
Net Debt / EBITDA Ratio
-15.54-12.61-9.83-8.15-11.13-8.70
Net Debt / FCF Ratio
-146.628.80-7.54-5.62-7.78-10.02
Asset Turnover
0.320.360.07---
Inventory Turnover
0.210.63----
Quick Ratio
0.010.030.010.010.010.01
Current Ratio
0.030.040.020.010.010.01
Return on Assets (ROA)
-78.11%-81.18%-209.45%-347.83%-271.02%-216.35%
Return on Capital Employed (ROCE)
5.20%6.00%9.30%11.30%8.10%10.60%
Earnings Yield
-5311.19%-6.28%-22.34%-6.51%-8.31%-5.40%
FCF Yield
-305.54%5.75%-17.92%-6.13%-6.71%-2.79%
Buyback Yield / Dilution
-0.45%-0.69%-0.35%-1.62%-2.38%-17.26%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.